Literature DB >> 23577622

Synergistic effect of doxycycline and fluconazole against Candida albicans biofilms and the impact of calcium channel blockers.

Yuan Gao1, Caiqing Zhang, Chunyan Lu, Ping Liu, Yan Li, Hui Li, Shujuan Sun.   

Abstract

Candida albicans is a clinically important fungus and is capable of forming biofilms, which contributes to the emergence of fluconazole resistance. Here, sessile minimum inhibitory concentrations (SMICs) of fluconazole combined with doxycycline against biofilms of C. albicans were determined, and the results of SMICs were compared with minimum inhibitory concentrations (MICs) of planktonic cells. SMICs and MICs were determined by microdilution checkerboard method, and the interactions between two drugs were interpreted by two models of fractional inhibitory concentration index and the percentage of growth difference (ΔE). For the biofilms formed over 4, 8, and 12 h, synergism was displayed by the combination of doxycycline(1-64 mg L(-1)) and fluconazole, and the fluconazole SMIC reduced from 64-512 mg L(-1) to 1-16 mg L(-1) against all the tested isolates. Calcium homeostasis is an important factor in growth of C. albicans. In this study, the impact of calcium channel blocker on the drug combination was observed by plate streaking and determined by liquid methods quantitatively. Obvious enhancement of antifungal effect appeared by combination of three drugs. These results show us that fluconazole combined with doxycycline could be effective against C. albicans biofilm, and the combined antifungal mechanism is associated with calcium.
© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  Candida albicans; biofilms; calcium channel blocker; drug interactions; drug resistance

Mesh:

Substances:

Year:  2013        PMID: 23577622     DOI: 10.1111/1567-1364.12048

Source DB:  PubMed          Journal:  FEMS Yeast Res        ISSN: 1567-1356            Impact factor:   2.796


  15 in total

Review 1.  Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.

Authors:  Jinhui Cui; Biao Ren; Yaojun Tong; Huanqin Dai; Lixin Zhang
Journal:  Virulence       Date:  2015       Impact factor: 5.882

Review 2.  Antifungal adjuvants: Preserving and extending the antifungal arsenal.

Authors:  Arielle Butts; Glen E Palmer; P David Rogers
Journal:  Virulence       Date:  2016-07-26       Impact factor: 5.882

Review 3.  Intestinal Infection of Candida albicans: Preventing the Formation of Biofilm by C. albicans and Protecting the Intestinal Epithelial Barrier.

Authors:  Ziyao Peng; Jianguo Tang
Journal:  Front Microbiol       Date:  2022-02-02       Impact factor: 5.640

4.  Discovery and Characterization of Two Classes of Selective Inhibitors of the Suppressor of the TCR Signaling Family of Proteins.

Authors:  Weijie Zhou; Yue Yin; Emery Smith; Jacqueline Chou; Justin Shumate; Louis Scampavia; Timothy P Spicer; Nicholas Carpino; Jarrod B French
Journal:  ACS Infect Dis       Date:  2018-12-14       Impact factor: 5.084

5.  Potent Synergy between Spirocyclic Pyrrolidinoindolinones and Fluconazole against Candida albicans.

Authors:  Ilandari Dewage Udara Anulal Premachandra; Kevin A Scott; Chengtian Shen; Fuqiang Wang; Shelley Lane; Haoping Liu; David L Van Vranken
Journal:  ChemMedChem       Date:  2015-08-12       Impact factor: 3.466

Review 6.  The effect of antibacterial and non-antibacterial compounds alone or associated with antifugals upon fungi.

Authors:  Maria M Azevedo; Rita Teixeira-Santos; Ana P Silva; Luisa Cruz; Elisabete Ricardo; Cidália Pina-Vaz; Acácio G Rodrigues
Journal:  Front Microbiol       Date:  2015-07-03       Impact factor: 5.640

7.  Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans.

Authors:  Shuyuan Liu; Longtao Yue; Wenrui Gu; Xiuyun Li; Liuping Zhang; Shujuan Sun
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

Review 8.  Drug repurposing strategies in the development of potential antifungal agents.

Authors:  Qian Zhang; Fangyan Liu; Meng Zeng; Yingyu Mao; Zhangyong Song
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-21       Impact factor: 4.813

Review 9.  Recent insights into Candida albicans biofilm resistance mechanisms.

Authors:  Lotte Mathé; Patrick Van Dijck
Journal:  Curr Genet       Date:  2013-08-25       Impact factor: 3.886

10.  The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms.

Authors:  Wei Jia; Haiyun Zhang; Caiyun Li; Gang Li; Xiaoming Liu; Jun Wei
Journal:  BMC Microbiol       Date:  2016-06-18       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.